Literature DB >> 35959193

Gliosarcoma With Glioneuronal and Rhabdomyosarcoma Components.

Murad Alturkustani1.   

Abstract

Gliosarcoma is a rare subtype of glioblastoma, isocitrate dehydrogenase (IDH) wildtype. This biphasic tumor has two components. The first one is glial and usually represented by glioblastoma. The second is a sarcomatous component usually represented by nonspecific spindle cell sarcoma. Rarely, different glial tumors could represent the non-sarcomatous component, including oligodendroglioma and ependymoma. There were only two reported cases in the literature with glioneuronal components (both were anaplastic ganglioglioma) as the non-sarcomatous component. This work reports a gliosarcoma in the right frontal lobe of a 13-year-old female with a glioneuronal tumor representing the non-sarcomatous component and a rhabdomyosarcoma representing the sarcomatous component. The child lived for only six months after the resection of the tumor. The short survival attests to the dismal prognosis of gliosarcoma regardless of the nature of the non-sarcomatous component.
Copyright © 2022, Alturkustani et al.

Entities:  

Keywords:  ganglioglioma; glioneuronal; gliosarcoma; rhabdomyosarcoma; tumor

Year:  2022        PMID: 35959193      PMCID: PMC9359697          DOI: 10.7759/cureus.26695

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  7 in total

1.  Anaplastic ganglioglioma with gliosarcoma component.

Authors:  Li Zhi; Li Yang; Huang Quan; Luo Bo-Ning; Liang Ying-Jie
Journal:  Pathology       Date:  2009       Impact factor: 5.306

2.  Anaplastic ganglioglioma with sarcomatous component: an immunohistochemical study and molecular analysis of p53 tumor suppressor gene.

Authors:  Hiroyoshi Suzuki; Taisuke Otsuki; Yuzo Iwasaki; Ryuichi Katakura; Hideshi Asano; Mamoru Tadokoro; Yoichi Suzuki; Fumiaki Tezuka; Hidehiro Takei
Journal:  Neuropathology       Date:  2002-03       Impact factor: 1.906

3.  Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.

Authors:  Guobin Zhang; Shengyue Huang; Junting Zhang; Zhen Wu; Song Lin; Yonggang Wang
Journal:  J Neurooncol       Date:  2016-01-02       Impact factor: 4.130

4.  Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.

Authors:  Fausto J Rodriguez; Bernd W Scheithauer; Robert Jenkins; Peter C Burger; Peter Rudzinskiy; Euvgeni Vlodavsky; Adam Schooley; Joseph Landolfi
Journal:  Am J Surg Pathol       Date:  2007-03       Impact factor: 6.394

5.  Gliosarcoma with prominent smooth muscle component (gliomyosarcoma): a report of 10 cases.

Authors:  Manisha Khanna; Fouzia Siraj; Prem Chopra; Sunita Bhalla; Subimal Roy
Journal:  Indian J Pathol Microbiol       Date:  2011 Jan-Mar       Impact factor: 0.740

6.  Ependymal tumors with sarcomatous change ("ependymosarcoma"): a clinicopathologic and molecular cytogenetic study.

Authors:  Fausto J Rodriguez; Bernd W Scheithauer; Arie Perry; Andre M Oliveira; Robert B Jenkins; Angelica Oviedo; Sverre J Mork; Cheryl A Palmer; Peter C Burger
Journal:  Am J Surg Pathol       Date:  2008-05       Impact factor: 6.394

7.  Clinical and epidemiological characteristics of pediatric gliosarcomas.

Authors:  Michael Karremann; Ulrike Rausche; Gudrun Fleischhack; Michaela Nathrath; Torsten Pietsch; Christof M Kramm; Johannes E A Wolff
Journal:  J Neurooncol       Date:  2009-10-06       Impact factor: 4.130

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.